Decreased serum profile of the interleukin-36α in polycystic ovary syndrome

Objective: The aim of this study was to determine the serum adiponectin and interleukin-36 alpha (IL-36α) levels in polycystic ovary syndrome (PCOS), and their relationship with obesity. Materials and methods: This observatory study included 80 PCOS patients and 58 controls. The clinical, biochemica...

Full description

Bibliographic Details
Main Authors: Semra Eroglu, Elcin Kal Cakmakliogullari
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Taiwanese Journal of Obstetrics & Gynecology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1028455921002527
_version_ 1818822974892933120
author Semra Eroglu
Elcin Kal Cakmakliogullari
author_facet Semra Eroglu
Elcin Kal Cakmakliogullari
author_sort Semra Eroglu
collection DOAJ
description Objective: The aim of this study was to determine the serum adiponectin and interleukin-36 alpha (IL-36α) levels in polycystic ovary syndrome (PCOS), and their relationship with obesity. Materials and methods: This observatory study included 80 PCOS patients and 58 controls. The clinical, biochemical, and hormonal parameters, and serum adiponectin and IL-36α levels of the patients were evaluated. Results: The serum IL-36α levels of the PCOS patients were significantly lower when compared to the control group, despite a similar mean body mass index (BMI) (P = 0.000). The adiponectin levels were significantly lower in the obese PCOS group when compared to the obese control group (P = 0.03). The plasma IL-36α level was positively correlated with adiponectin level, but negatively correlated with the serum LH level (P = 0.000 and P = 0.004, respectively). Using receiver operating characteristic analysis, the cut-off value of IL-36α was calculated as 0.815 for PCOS. In the multiple binary logistic regression analysis, IL-36α (OR [95% CI] 0.432 [0.303, 0.616], P < 0.001) and adiponectin (OR [95% CI] 1.044 [1.005, 1.084], P = 0.028) were determined to be significantly associated with PCOS. Conclusion: A reduced IL-36α level may play a role in the pathogenesis of ovulatory disfunction and insulin resistance in PCOS patients. Further studies are needed to understand the pathogenic and clinical significance of the IL-36 system in PCOS.
first_indexed 2024-12-18T23:32:37Z
format Article
id doaj.art-d18354ad8d6544e9adb046c087856c83
institution Directory Open Access Journal
issn 1028-4559
language English
last_indexed 2024-12-18T23:32:37Z
publishDate 2021-11-01
publisher Elsevier
record_format Article
series Taiwanese Journal of Obstetrics & Gynecology
spelling doaj.art-d18354ad8d6544e9adb046c087856c832022-12-21T20:47:38ZengElsevierTaiwanese Journal of Obstetrics & Gynecology1028-45592021-11-0160610181022Decreased serum profile of the interleukin-36α in polycystic ovary syndromeSemra Eroglu0Elcin Kal Cakmakliogullari1Department of Gynecology and Obstetrics, Samsun University, Konya, Turkey; Corresponding author. Samsun University, Department of Gynecology and Obstetrics, Lise Street, No: 83, Samsun, Turkey. Fax: +90 3622309100.Department of Microbiology, Karabuk University, Karabuk, TurkeyObjective: The aim of this study was to determine the serum adiponectin and interleukin-36 alpha (IL-36α) levels in polycystic ovary syndrome (PCOS), and their relationship with obesity. Materials and methods: This observatory study included 80 PCOS patients and 58 controls. The clinical, biochemical, and hormonal parameters, and serum adiponectin and IL-36α levels of the patients were evaluated. Results: The serum IL-36α levels of the PCOS patients were significantly lower when compared to the control group, despite a similar mean body mass index (BMI) (P = 0.000). The adiponectin levels were significantly lower in the obese PCOS group when compared to the obese control group (P = 0.03). The plasma IL-36α level was positively correlated with adiponectin level, but negatively correlated with the serum LH level (P = 0.000 and P = 0.004, respectively). Using receiver operating characteristic analysis, the cut-off value of IL-36α was calculated as 0.815 for PCOS. In the multiple binary logistic regression analysis, IL-36α (OR [95% CI] 0.432 [0.303, 0.616], P < 0.001) and adiponectin (OR [95% CI] 1.044 [1.005, 1.084], P = 0.028) were determined to be significantly associated with PCOS. Conclusion: A reduced IL-36α level may play a role in the pathogenesis of ovulatory disfunction and insulin resistance in PCOS patients. Further studies are needed to understand the pathogenic and clinical significance of the IL-36 system in PCOS.http://www.sciencedirect.com/science/article/pii/S1028455921002527Polycystic ovary syndromeObesityInterleukin-36Adiponectin
spellingShingle Semra Eroglu
Elcin Kal Cakmakliogullari
Decreased serum profile of the interleukin-36α in polycystic ovary syndrome
Taiwanese Journal of Obstetrics & Gynecology
Polycystic ovary syndrome
Obesity
Interleukin-36
Adiponectin
title Decreased serum profile of the interleukin-36α in polycystic ovary syndrome
title_full Decreased serum profile of the interleukin-36α in polycystic ovary syndrome
title_fullStr Decreased serum profile of the interleukin-36α in polycystic ovary syndrome
title_full_unstemmed Decreased serum profile of the interleukin-36α in polycystic ovary syndrome
title_short Decreased serum profile of the interleukin-36α in polycystic ovary syndrome
title_sort decreased serum profile of the interleukin 36α in polycystic ovary syndrome
topic Polycystic ovary syndrome
Obesity
Interleukin-36
Adiponectin
url http://www.sciencedirect.com/science/article/pii/S1028455921002527
work_keys_str_mv AT semraeroglu decreasedserumprofileoftheinterleukin36ainpolycysticovarysyndrome
AT elcinkalcakmakliogullari decreasedserumprofileoftheinterleukin36ainpolycysticovarysyndrome